Unlike when the 'Mythical Island' mini-expansion dropped late last year, the arrival of 'Space-Time Smackdown' has pushed the ...
AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...